Historical overview of the rationale for the pharmacological use of prolonged-release fampridine in multiple sclerosis

By Fernandez Oscar   Berger Thomas   Hartung Hans-Peter   Putzki Norman  

Expert Review of Clinical Pharmacology, Vol. 5, Iss. 6, 2012-11 ,pp. : 649-665

Informa Healthcare

Access to resources Recommend Favorite

Prolonged-release fampridine: a guide to its use in multiple sclerosis in the EU

By Lyseng-Williamson Katherine A.  

Drugs & Therapy Perspectives, Vol. 28, Iss. 12, 2012-12 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Oral drugs for the treatment of Multiple Sclerosis

By  

PHARMAKON, Vol. 2, Iss. 6, 2014-11 ,pp. : 396-402

Govi-Verlag

Access to resources Recommend Favorite

Teriflunomide: a novel oral treatment for relapsing multiple sclerosis

By Sartori Arianna   Carle Dawn   Freedman Mark S  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 7, 2014-05 ,pp. : 1019-1027

Informa Healthcare

Access to resources Recommend Favorite

Oral Agents in Multiple Sclerosis

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 14, Iss. 1, 2015-03 ,pp. : 15-25

Bentham Science Publishers

Access to resources Recommend Favorite